NDC 00143-9393-10 10

Remifentanil 5 mg Vial [Ultiva] 2024-07-25

Supplier	Hikma Pharmaceuticals USA Inc.
Availability Status	ASHP Shortage + QS Availability Issues (2024-07-25)
Status Description	QuicksortRx has identified an availability disruption across multiple channels, and ASHP has published an active drug shortage for this product. See their website for more information.
Quicksort Status	Availability Issues Detected (2024-07-25)
ASHP Status	ASHP Shortage Declared (2024-06-24)
QUMI Product Code	h5w80rp (QuicksortRx Universal Medication Identifier)

Label Images Coming Soon!

NDC	Package Count	Supplier	Description	Status	Updated
63323-0725-10	10	Fresenius Kabi USA, LLC	Remifentanil 5 mg Vial [Ultiva]	ASHP Shortage + QS Availability Issues	2024-08-10
67457-0198-10	10	Mylan Institutional LLC	Remifentanil 5 mg Vial [Ultiva]	QuicksortRx NDC Availability Disruption	2024-07-31
67457-0914-05	10	Mylan Institutional LLC	Remifentanil 5 mg Vial [Ultiva]	No Availability Issues Detected

QUMI Codes

QUMI Code	Route	Strength	Form	NDC Count	Description
s0v036q	Injectable	3 mg	Vial	6	Remifentanil 1 mg Vial
wm8tsjr	Injectable	5 mg	Vial	5	Remifentanil 2 mg Vial

Previous Status	Status Start Date	Status End Date
ASHP Shortage + QS Availability Issues	2024-07-25	Current
No Availability Issues Detected		2024-07-25

RXCUI:	1729710
Dosage Form:	Vial
Dosage Route:	INJECTABLE
Strength:	10
Measure:	mg
ANDA:	ANDA210594
Generic Description:	REMIFENTANIL HCl
DEA:	2